Among the genes affected by TET1-mediated changes in methylation status, several notable ones include HMGN1, NSMCE2, UIMC1, RFC2 and HMGA2, most affect the proliferation of HCC cells under sorafenib treatment (Fig S10). Here, HMGA2 is linked to hepatocellular carcinoma.